Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SHE:301093)

SHE:301093 Revenue

Jiangsu Hualan New Pharmaceutical Material had revenue of 129.56M CNY in the quarter ending March 31, 2026, a decrease of -11.00%. This brings the company's revenue in the last twelve months to 603.43M, down -0.33% year-over-year. In the year 2025, Jiangsu Hualan New Pharmaceutical Material had annual revenue of 619.45M with 5.63% growth.

• Revenue (ttm): 603.43M
• Revenue Growth: -0.33%
• P/S Ratio: 34.58
• Revenue / Employee: 648.85K
• Employees: 930
• Market Cap: 20.87B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	619.45M	33.04M	5.63%
Dec 31, 2024	586.41M	-36.51M	-5.86%
Dec 31, 2023	622.92M	38.79M	6.64%
Jan 1, 2023	584.14M	-236.73M	-28.84%
Jan 1, 2022	820.87M	374.54M	83.92%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error